Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Lazarus

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Imaging and Biology|February 19, 2026
Template-Directed RIG-I Agonist Assembly for Image-guided Targeted Cancer ImmunotherapySubrata K Ghosh, Douglas Lazarus, Neil Robertson, et al.
Breast Cancer Research and Treatment|April 3, 2015
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancerSarah J Conley, Trenton L Baker, Joseph P Burnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancerElizabeth Pham, Michael J Birrer, Scott Eliasof, et al.
Cancer Research|June 22, 2016
Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast CancerElizabeth Pham, Melissa Yin, Christian G Peters, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleScott Eliasof, Douglas Lazarus, Christian G Peters, et al.
Molecular Pharmaceutics|February 3, 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric NanopharmaceuticalSonke Svenson, Roy I Case, Roderick O Cole, et al.
Journal of Medicinal Chemistry|October 9, 2019
Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery PlatformChester A Metcalf, Sonke Svenson, Jungyeon Hwang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Imaging and Biology|February 19, 2026
Template-Directed RIG-I Agonist Assembly for Image-guided Targeted Cancer ImmunotherapySubrata K Ghosh, Douglas Lazarus, Neil Robertson, et al.
Breast Cancer Research and Treatment|April 3, 2015
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancerSarah J Conley, Trenton L Baker, Joseph P Burnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancerElizabeth Pham, Michael J Birrer, Scott Eliasof, et al.
Cancer Research|June 22, 2016
Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast CancerElizabeth Pham, Melissa Yin, Christian G Peters, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticleScott Eliasof, Douglas Lazarus, Christian G Peters, et al.
Molecular Pharmaceutics|February 3, 2016
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric NanopharmaceuticalSonke Svenson, Roy I Case, Roderick O Cole, et al.
Journal of Medicinal Chemistry|October 9, 2019
Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery PlatformChester A Metcalf, Sonke Svenson, Jungyeon Hwang, et al.
Pageof 1